Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 11;13(4):674-680.
doi: 10.1021/acsmedchemlett.1c00711. eCollection 2022 Apr 14.

C20- nor-Abietane and Three Abietane Diterpenoids from Plectranthus mutabilis Leaves as P-Glycoprotein Modulators

Affiliations

C20- nor-Abietane and Three Abietane Diterpenoids from Plectranthus mutabilis Leaves as P-Glycoprotein Modulators

Epole N Ntungwe et al. ACS Med Chem Lett. .

Abstract

In this study, a bioguided fractionation of Plectranthus mutabilis extract was performed by chromatographic methods. It yielded one new nor-abietane diterpene, mutabilol (1), and three known abietanes, coleon-U-quinone (2), 8α,9α-epoxycoleon-U-quinone (3), and coleon U (4). The abietane diterpenoid 5 was also tentatively identified using HPLC-MS/MS. Moreover, the extract profile and quantification of each isolated compound were determined by HPLC-DAD. Compound 4 was the major compound in the extract. Compounds 2-4 were found to be selective toward cancer cell lines and were able to inhibit P-glycoprotein (P-gp) activity in NCI-H460/R cells at longer exposure of 72 h and consequently revert doxorubicin (DOX) resistance in subsequent combined treatment. None of the compounds influenced the P-gp expression in NCI-H460/R cells, while the extract significantly increased it.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
Structures of compounds 1–4 from P. mutabilis.
Figure 2
Figure 2
Key 1H–1H COSY (bold lines) and HMBC (blue arrows) correlations for compound 1.
Figure 3
Figure 3
Electrophilic (fk), nucleophilic (fk+), and radical (fk0) Fukui functions of 24. The higher condensed Fukui indexes are indicated as green circles, red triangles, and blue arrows, respectively, representing the sites in the molecules that are most susceptible to a radical attack, most nucleophilic, and most electrophilic.
Figure 4
Figure 4
Electrophilic Fukui functions (fk) and Gibbs free energies of formation for anions derived from deprotonation of coleon U (4) at hydroxyl positions on (a) C11 and (b) C14.
Scheme 1
Scheme 1
Figure 5
Figure 5
Effects of compounds and the extract on ABCB1 expression. The mean fluorescence intensity (MFI) of untreated NCI-H460/R cells was set to 100 and used for the comparison of other MFI values (for untreated NCI-H460 cells and treated NCI-H460/R cells) in GraphPad Prism 6 software (unpaired t test). The MFI was calculated from three independent experiments. A difference from untreated NCI-H460/R cells was considered to be significant if p < 0.05 (*) or p < 0.001 (***).

References

    1. Gonçalves B. M. F.; Cardoso D. S. P.; Ferreira M.-J. U. Overcoming Multidrug Resistance: Flavonoid and Terpenoid Nitrogen-Containing Derivatives as ABC Transporter Modulators. Molecules 2020, 25 (15), 336410.3390/molecules25153364. - DOI - PMC - PubMed
    1. Kryczka J.; Boncela J. Cell Migration Related to MDR—Another Impediment to Effective Chemotherapy?. Molecules 2018, 23 (2), 331.10.3390/molecules23020331. - DOI - PMC - PubMed
    1. Wang S.; Wang S. Q.; Teng Q. X.; Yang L.; Lei Z. N.; Yuan X. H.; Huo J. F.; Chen X. B.; Wang M.; Yu B.; Chen Z. S.; Liu H. M. Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5-a]Pyrimidine Derivatives as Highly Potent and Orally Active ABCB1Modulators. J. Med. Chem. 2020, 63 (24), 15979–15996. 10.1021/acs.jmedchem.0c01741. - DOI - PubMed
    1. Raub T. J. P-Glycoprotein Recognition of Substrates and Circumvention through Rational Drug Design. Mol. Pharmaceutics 2006, 3 (1), 3–25. 10.1021/mp0500871. - DOI - PubMed
    1. Xiao Z.; Morris-Natschke S. L.; Lee K.-H. Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates. Med. Res. Rev. 2016, 36 (1), 32–91. 10.1002/med.21377. - DOI - PMC - PubMed